The Company passes final phase of certification process to achieve Funding Eligible status.
Nightingale On Demand continues its reign as the number one ranked EMR by market share under Ontario's New EMR Adoption Program.
MARKHAM, ON, March 21, 2012 /CNW/ - Nightingale Informatix Corporation ("Nightingale" or the "Company") (TSXV: NGH), an application service provider (ASP) of electronic medical record (EMR) software and related services, announced today that it has completed and passed the "live" Reference Site phase for OntarioMD's EMR Specification 4.0 and has achieved Funding Eligible status. Established by the Ontario Medical Association and the Ministry of Health and Long-Term Care, OntarioMD manages the EMR Adoption Program, which funds and assists physicians to acquire, implement and adopt IT.
Nightingale is one of four companies currently identified as Specification 4.0 Funding Eligible, and the second returning company to complete the process. Part of the requirement for Specification 4.0 was the integration with the Ontario Lab Information System (OLIS) and the Hospital Report Manager (HRM). "The Ontario EMR Specification 4.0 provides our users with enhanced interoperability and functionality that improves our users' access to clinical information, and which ultimately improves patient care. This is yet another step towards creating a fully integrated and interoperable healthcare system" said Sam Chebib, President and CEO of Nightingale.
He continued "As the largest ASP EMR vendor in Canada, Nightingale is committed to maintaining its Funding Eligible status in all jurisdictions where we operate." Nightingale On Demand continues its reign as the number one ranked EMR in Ontario's New EMR Adoption Program by market share with a 21.8% market share and as the leading ASP provider with 77% market share.
Nightingale is one of the fastest growing health care service and software companies in North America and is recognized as an industry leader in Web-based clinician and community based electronic medical records (EMR) serving the needs of small primary care practices, multi-physician outpatient clinics, and large scale regional health organizations and networks. Coupled with integrated practice management, transcription and revenue cycle management, Nightingale's comprehensive service offering allows customers to enhance patient care, increase revenue opportunities and optimize operations. Nightingale is continuously innovating and enhancing its services to meet the needs of its growing and diverse customer base. Nightingale - Healthcare connected. www.nightingalemd.com
Forward Looking Statement
This press release contains "forward-looking statements" respecting the issuance and cancellation of securities of the Company within the meaning of applicable Canadian securities legislation. Generally, forward-looking statements can be identified by the use of forward- looking terminology such as "plans", "expects" or "does not expect", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may" ,"could", "would", "might", "occur" or "be achieved". Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Nightingale to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the speculative nature of the medical software industry, which is affected by numerous factors beyond Nightingale's control; the ability of Nightingale to successfully secure customer contracts and the timing of securing such contracts; the ability of Nightingale to complete and successfully integrate its acquisitions on an accretive basis, Nightingale's access to debt and capital facilities, including compliance with current debt arrangements; the existence of present and possible future government regulation; the significant competition that exists in the medical software industry; the early stage of Nightingale's business, and risks associated with early stage companies, including uncertainty of revenues, markets and profitability and the need to raise additional funding. All material assumptions used in making forward-looking statements are based on management's knowledge of current business conditions and expectations of future business conditions and trends. Certain material factors or assumptions applied by management in making forward-looking statements, include without limitation, factors and assumptions regarding future trends in healthcare spending, economic conditions affecting Nightingale and North American economies; Nightingale's ability to continue to fund its business, rates of customer defaults, relationships with, and payments to lenders, as well as Nightingale's operating cost structure.
Although Nightingale has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Nightingale does not undertake to update any forward-looking statements that are incorporated by reference herein, except in accordance with applicable securities laws. Further information on Nightingale Informatix Corporation is available at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information:
Sharmeen Arafat, Marketing Manager
Nightingale Informatix Corporation
Kristen Dickson, Account Executive
The Equicom Group
Tel: 416-815-0700 ext. 273